3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
245
Precursor Cell Lymphoblastic Leukemia-Lymphoma
143
Myelodysplastic Syndromes
142
Leukemia, Lymphocytic, Chronic, B-Cell
139
Leukemia
127
Multiple Myeloma
117
Lymphoma
115
Lymphoma, Non-Hodgkin
112
Recurrence
79
Hematologic Neoplasms
74
Melanoma
68
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
67
Hodgkin Disease
67
Lymphoma, B-Cell
61
Lymphoma, Mantle-Cell
51
Lymphoma, Large B-Cell, Diffuse
50
Lymphoma, Follicular
50
Burkitt Lymphoma
41
Ovarian Neoplasms
40
Neoplasms
39
Myeloproliferative Disorders
39
Neoplasm Metastasis
34
Lymphoma, B-Cell, Marginal Zone
30
Graft vs Host Disease
29
Neoplasms, Plasma Cell
28
Carcinoma, Non-Small-Cell Lung
27
Breast Neoplasms
27
Leukemia, Biphenotypic, Acute
25
Primary Myelofibrosis
24
Anemia, Refractory, with Excess of Blasts
23
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Chickenpox
×
fludarabine
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled